Empagliflozin-A New Chance for Patients with Chronic Heart Failure
The heart failure (HF) epidemic is one of the challenges that has been faced by the healthcare system worldwide for almost 25 years. With an ageing world population and a fast-paced lifestyle that promotes the development of cardiovascular disease, the number of people suffering from heart failure w...
Saved in:
Main Authors: | Klaudia Kowalska (Author), Justyna Walczak (Author), Joanna Femlak (Author), Ewelina Młynarska (Author), Beata Franczyk (Author), Jacek Rysz (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy
by: Klaudia Kowalska, et al.
Published: (2022) -
Arterial Hypertension-Oxidative Stress and Inflammation
by: Julia Krzemińska, et al.
Published: (2022) -
Role of Uremic Toxins, Oxidative Stress, and Renal Fibrosis in Chronic Kidney Disease
by: Weronika Frąk, et al.
Published: (2024) -
Selenium as a Modulator of Redox Reactions in the Prevention and Treatment of Cardiovascular Diseases
by: Klaudia Leszto, et al.
Published: (2024) -
Progress of patients hospitalized with acute heart failure treated with empagliflozin
by: Manuel Raya-Cruz, et al.
Published: (2024)